ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА

In 24 patients with type 1 and 2 diabetes and 12 donors was shown that in diabetes the Nox releasing of membrane of blood formations is significantly enhanced. This phenomenon is more pronounced in type 2 diabetes, indicating a greater violation of the stability of erythrocyte membranes (EM) and ser...

Full description

Saved in:
Bibliographic Details
Main Author: Е. А. Агаджанова
Format: Article
Language:Russian
Published: SINAPS LLC 2014-06-01
Series:Архивъ внутренней медицины
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/301
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839572873978576896
author Е. А. Агаджанова
author_facet Е. А. Агаджанова
author_sort Е. А. Агаджанова
collection DOAJ
description In 24 patients with type 1 and 2 diabetes and 12 donors was shown that in diabetes the Nox releasing of membrane of blood formations is significantly enhanced. This phenomenon is more pronounced in type 2 diabetes, indicating a greater violation of the stability of erythrocyte membranes (EM) and serum exosomes (SE). Under the influence of exogenous glucose releasing of Nox is further enhanced to a greater extent, in particular from SE. Influenced insulin in vitro releasing Nox in EM and SE also increases in. Based on a number of data , it has been suggested the possible role of Nox as the insulin receptor. It is shown that in the serum membranous structures of patients with type 1 diabetes treated with insulin, as well as the addition of insulin into the blood of patients with type 2 diabetes the releasing of Nox was significantly higher than in healthy donors. In the presence of Embryonal antitumor modulator of Mkrtchyan (EATM) the releasing of Nox is significantly inhibited, especially in patients with type 2 diabetes. Suppression of the Nox isoforms releasing of EM and SE in patients with diabetes under the influence EATM can be considered as a possible mechanism of its membrane stabilizing effect in vivo.
format Article
id doaj-art-9fb19efb1ada4a36b50b8045c23739b3
institution Matheson Library
issn 2226-6704
2411-6564
language Russian
publishDate 2014-06-01
publisher SINAPS LLC
record_format Article
series Архивъ внутренней медицины
spelling doaj-art-9fb19efb1ada4a36b50b8045c23739b32025-08-04T14:09:43ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642014-06-0103394510.20514/2226-6704-2014-0-3-39-45314ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРАЕ. А. Агаджанова0Ереванский государственный медицинский университет; Институт биохимии им. Г.Х. Бунятяна НАН РАIn 24 patients with type 1 and 2 diabetes and 12 donors was shown that in diabetes the Nox releasing of membrane of blood formations is significantly enhanced. This phenomenon is more pronounced in type 2 diabetes, indicating a greater violation of the stability of erythrocyte membranes (EM) and serum exosomes (SE). Under the influence of exogenous glucose releasing of Nox is further enhanced to a greater extent, in particular from SE. Influenced insulin in vitro releasing Nox in EM and SE also increases in. Based on a number of data , it has been suggested the possible role of Nox as the insulin receptor. It is shown that in the serum membranous structures of patients with type 1 diabetes treated with insulin, as well as the addition of insulin into the blood of patients with type 2 diabetes the releasing of Nox was significantly higher than in healthy donors. In the presence of Embryonal antitumor modulator of Mkrtchyan (EATM) the releasing of Nox is significantly inhibited, especially in patients with type 2 diabetes. Suppression of the Nox isoforms releasing of EM and SE in patients with diabetes under the influence EATM can be considered as a possible mechanism of its membrane stabilizing effect in vivo.https://www.medarhive.ru/jour/article/view/301diabetes mellitusnoxglucoseinsulinmkrtchyan embryonic antitumor modulator
spellingShingle Е. А. Агаджанова
ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА
Архивъ внутренней медицины
diabetes mellitus
nox
glucose
insulin
mkrtchyan embryonic antitumor modulator
title ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА
title_full ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА
title_fullStr ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА
title_full_unstemmed ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА
title_short ВЛИЯНИЕ ГЛЮКОЗЫ И ИНСУЛИНА НА АКТИВНОСТЬ NOX В КРОВИ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И РЕГУЛЯЦИЯ ЕЁ ПОСРЕДСТВОМ ЭМБРИОНАЛЬНОГО ПРОТИВООПУХОЛЕВОГО МОДУЛЯТОРА
title_sort влияние глюкозы и инсулина на активность nox в крови больных сахарным диабетом и регуляция её посредством эмбрионального противоопухолевого модулятора
topic diabetes mellitus
nox
glucose
insulin
mkrtchyan embryonic antitumor modulator
url https://www.medarhive.ru/jour/article/view/301
work_keys_str_mv AT eaagadžanova vliânieglûkozyiinsulinanaaktivnostʹnoxvkrovibolʹnyhsaharnymdiabetomiregulâciâeëposredstvomémbrionalʹnogoprotivoopuholevogomodulâtora